← zu den Großinvestoren
Commodore Capital Lp
institutioneller Anleger · Portfolio $1.68 Mrd. · 33 Positionen · Bericht zum 30.06.2026
Aktienpositionen Bericht für 30.06.2026, eingereicht am 14.08.2026; Veränderung – ggü. 31.03.2026 · 0
| Unternehmen | Aktien | Wert | % des Portfolios | Veränderung im Quartal |
|---|
In Unternehmen Unserer Datenbank 18
| Unternehmen | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| InflaRx N.V. | 49.03% | 7 300 000 | 2026-06-30 |
| AN2 Therapeutics Inc | 7.77% | 2 933 680 | 2026-06-30 |
| Assembly Biosciences Inc | 6.95% | 1 415 000 | 2026-06-30 |
| Alto Neuroscience, Inc. | 6.94% | 2 723 196 | 2026-06-30 |
| PepGen Ltd | 6.46% | 4 475 000 | 2026-06-30 |
| Research Alliance Corporatio… | 6.43% | 500 000 | 2026-06-30 |
| Vistagen Therapeutics, Inc. | 6.28% | 2 788 620 | 2026-06-30 |
| Editas Medicine Inc | 5.79% | 8 889 000 | 2026-06-30 |
| Perspective Therapeutics Inc… | 5.55% | 6 336 782 | 2026-06-30 |
| Relay Therapeutics Inc | 5.48% | 12 000 000 | 2026-06-30 |
| LeonaBio, Inc. | 4.94% | 464 398 | 2026-06-30 |
| Century Therapeutics Inc | 4.8% | 8 695 652 | 2026-06-30 |
| LB PHARMACEUTICALS INC | 4.65% | 1 500 000 | 2026-06-30 |
| Enliven Therapeutics Inc. | 4.47% | 3 275 000 | 2026-06-30 |
| Inhibikase Therapeutics Inc | 3.87% | 5 397 488 | 2026-06-30 |
| Zura Bio Limited Class A | 3.37% | 3 250 000 | 2026-06-30 |
| SAB Biotherapeutics Inc | 3.15% | 2 870 000 | 2026-06-30 |
| Tyra Biosciences Inc | 3.14% | 1 875 000 | 2026-06-30 |
Anzeige